RVMD insider filings

Revolution Medicines, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-18. Screen RVMD transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 24 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Kelsey Stephen Michael — See Remarks3—16 legs · 125,260 sh · $24,393,5316
GOLDSMITH MARK A — See Remarks, Director2—20 legs · 99,988 sh · $20,778,0452
Kim Lorence H. — Director2—14 legs · 73,090 sh · $14,967,125—
Cislini Jeff — SVP & General Counsel3—9 legs · 61,025 sh · $12,733,4784
Anders Jack — Chief Financial Officer2—13 legs · 39,803 sh · $7,532,2014
Mancini Anthony — See Remarks6—12 legs · 25,815 sh · $5,192,09010
ANDERSON ELIZABETH M — Director1—5 legs · 10,143 sh · $1,958,0162
Sandler Alan B. — Chief Development Officer2—7 legs · 6,650 sh · $1,343,2352
Horn Margaret A — Chief Operating Officer1—2 legs · 4,967 sh · $989,613—
Borellini Flavia — Director1——2

+1 more insider in the window, not shown — every filing appears in the table below.

Recent insider filings — Revolution Medicines, Inc.

FiledFormInsiderReported transactionsSource
2026-11-184Kelsey Stephen Michael — See RemarksOption exercise (M): 27,160 @ $18.56 · Sale (S): 11,542 @ $166.75 · Sale (S): 3,627 @ $167.66 · Sale (S): 8,039 @ $168.64 · Sale (S): 3,052 @ $169.46 · Sale (S): 700 @ $170.40 · +2 moreEDGAR
2026-11-174Borellini Flavia — DirectorOption exercise (M): 2,500 @ $37.54 · Option exercise (M): 2,500 (derivative) @ $0EDGAR
2026-11-134Borisy Alexis — DirectorGift (G): 10,625 @ $0EDGAR
2026-11-134Anders Jack — Chief Financial OfficerOption exercise (M): 15,900 @ $42.45 · Option exercise (M): 19,850 @ $18.56 · Sale (S): 3,499 @ $181.04 · Sale (S): 5,776 @ $182.09 · Sale (S): 2,700 @ $182.87 · Sale (S): 1,900 @ $184.02 · +9 moreEDGAR
2026-11-124Mancini Anthony — See RemarksOption exercise (M): 810 @ $33.62 · Option exercise (M): 1 @ $102.02 · Sale (S): 811 @ $200 · Option exercise (M): 810 (derivative) @ $0 · Option exercise (M): 1 (derivative) @ $0EDGAR
2026-10-284Mancini Anthony — See RemarksOption exercise (M): 2,310 @ $33.62 · Sale (S): 2,310 @ $186.99 · Option exercise (M): 2,310 (derivative) @ $0EDGAR
2026-10-014Sandler Alan B. — Chief Development OfficerOption exercise (M): 6,000 @ $58.84 · Sale (S): 2,200 @ $200.82 · Sale (S): 1,609 @ $201.72 · Sale (S): 1,000 @ $202.81 · Sale (S): 1,199 @ $203.91 · Sale (S): 301 @ $204.72 · +1 moreEDGAR
2026-09-294Cislini Jeff — SVP & General CounselSale (S): 765 @ $207.32EDGAR
2026-09-284Mancini Anthony — See RemarksSale (S): 587 @ $200 · Option exercise (M): 3,121 @ $33.62 · Sale (S): 3,121 @ $200.54 · Option exercise (M): 3,121 (derivative) @ $0EDGAR
2026-09-244ANDERSON ELIZABETH M — DirectorOption exercise (M): 5,070 @ $1.12 · Sale (S): 910 @ $191.85 · Sale (S): 4,985 @ $192.54 · Sale (S): 2,648 @ $193.44 · Sale (S): 1,500 @ $194.59 · Sale (S): 100 @ $195.15 · +1 moreEDGAR
2026-09-224Mancini Anthony — See RemarksSale (S): 1,764 @ $196.94EDGAR
2026-09-184Kelsey Stephen Michael — See RemarksSale (S): 85 @ $195.01 · Sale (S): 5,484 @ $199.30EDGAR
2026-09-184Mancini Anthony — See RemarksSale (S): 27 @ $195.05 · Sale (S): 1,747 @ $199.30EDGAR
2026-09-184Sandler Alan B. — Chief Development OfficerSale (S): 5 @ $194.96 · Sale (S): 336 @ $199.30EDGAR
2026-09-184Cislini Jeff — SVP & General CounselSale (S): 52 @ $195.01 · Sale (S): 3,314 @ $199.30EDGAR
2026-09-184GOLDSMITH MARK A — See Remarks, DirectorSale (S): 213 @ $195.01 · Sale (S): 13,775 @ $199.30EDGAR
2026-09-184Horn Margaret A — Chief Operating OfficerSale (S): 76 @ $195.01 · Sale (S): 4,891 @ $199.30EDGAR
2026-09-184Anders Jack — Chief Financial OfficerSale (S): 61 @ $195 · Sale (S): 3,992 @ $199.30EDGAR
2026-09-154Kelsey Stephen Michael — See RemarksOption exercise (M): 52,500 @ $42.45 · Option exercise (M): 40,031 @ $40.74 · Sale (S): 800 @ $198.55 · Sale (S): 11,833 @ $200.11 · Sale (S): 13,368 @ $200.78 · Sale (S): 21,447 @ $201.75 · +6 moreEDGAR
2026-09-144Mancini Anthony — See RemarksOption exercise (M): 9,363 @ $33.62 · Sale (S): 6,019 @ $203.28 · Sale (S): 5,530 @ $204.14 · Sale (S): 2,420 @ $205.05 · Sale (S): 1,179 @ $206.10 · Sale (S): 300 @ $207.17 · +1 moreEDGAR
2026-09-104Kim Lorence H. — DirectorSale (S): 706 @ $206.60 · Sale (S): 999 @ $207.33 · Sale (S): 3,587 @ $208.55 · Sale (S): 2,853 @ $209.56 · Sale (S): 4,730 @ $210.50 · Sale (S): 3,844 @ $211.36 · +1 moreEDGAR
2026-09-024Kim Lorence H. — DirectorSale (S): 300 @ $200.56 · Sale (S): 6,597 @ $201.47 · Sale (S): 12,919 @ $202.48 · Sale (S): 26,160 @ $203.55 · Sale (S): 7,271 @ $204.35 · Sale (S): 2,128 @ $205.19 · +1 moreEDGAR
2026-08-254GOLDSMITH MARK A — See Remarks, DirectorOption exercise (M): 80,000 @ $4.73 · Sale (S): 5,128 @ $207.23 · Sale (S): 24,917 @ $208.37 · Sale (S): 35,938 @ $209.26 · Sale (S): 3,813 @ $210.25 · Sale (S): 6,583 @ $211.33 · +14 moreEDGAR
2026-08-254Cislini Jeff — General CounselOption exercise (M): 29,680 @ $18.56 · Option exercise (M): 26,600 @ $21.61 · Sale (S): 3,400 @ $207.24 · Sale (S): 17,323 @ $208.37 · Sale (S): 25,817 @ $209.25 · Sale (S): 2,540 @ $210.26 · +4 moreEDGAR
2026-07-014Patel Sushil — DirectorOption exercise (M): 2,955 @ $37.54 · Sale (S): 300 @ $183.17 · Sale (S): 900 @ $184.59 · Sale (S): 1,100 @ $185.90 · Sale (S): 858 @ $186.92 · Sale (S): 300 @ $187.83 · +5 moreEDGAR
2026-06-264Anders Jack — Chief Financial OfficerOption exercise (M): 20,000 @ $18.56 · Sale (S): 4,553 @ $167.34 · Sale (S): 9,496 @ $168.20 · Sale (S): 5,651 @ $169.24 · Sale (S): 300 @ $170.32 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2026-06-234Kim Lorence H. — DirectorGrant/award (A): 1,191 @ $0 · Grant/award (A): 3,127 (derivative) @ $0EDGAR
2026-06-234ANDERSON ELIZABETH M — DirectorGrant/award (A): 1,191 @ $0 · Grant/award (A): 3,127 (derivative) @ $0EDGAR
2026-06-234Horning Sandra — DirectorGrant/award (A): 1,191 @ $0 · Grant/award (A): 3,127 (derivative) @ $0EDGAR
2026-06-234Clyburn Frank — DirectorGrant/award (A): 1,191 @ $0 · Grant/award (A): 3,127 (derivative) @ $0EDGAR
2026-06-234Patel Sushil — DirectorGrant/award (A): 1,191 @ $0 · Grant/award (A): 3,127 (derivative) @ $0EDGAR
2026-06-234Borellini Flavia — DirectorGrant/award (A): 1,191 @ $0 · Grant/award (A): 3,127 (derivative) @ $0EDGAR
2026-06-234Borisy Alexis — DirectorGrant/award (A): 1,191 @ $0 · Grant/award (A): 3,127 (derivative) @ $0EDGAR
2026-06-184Mancini Anthony — See RemarksSale (S): 4,615 @ $156.12EDGAR
2026-06-184Cislini Jeff — General CounselSale (S): 2,157 @ $156.12EDGAR
2026-06-184Anders Jack — Chief Financial OfficerSale (S): 2,722 @ $156.12EDGAR
2026-06-184Kelsey Stephen Michael — See RemarksSale (S): 4,175 @ $156.12EDGAR
2026-06-184GOLDSMITH MARK A — See Remarks, DirectorSale (S): 10,020 @ $156.12EDGAR
2026-06-174Horn Margaret A — Chief Operating OfficerOption exercise (M): 15,546 @ $40.74 · Option exercise (M): 44,854 @ $29.80 · Sale (S): 60,400 @ $160.17 · Sale (S): 3,575 @ $156.12 · Option exercise (M): 573 @ $40.74 · Option exercise (M): 3,302 @ $29.80 · +7 moreEDGAR
2026-06-154Horn Margaret A — Chief Operating OfficerOption exercise (M): 1,094 @ $42.45 · Option exercise (M): 8,906 @ $40.74 · Sale (S): 1,315 @ $144.28 · Sale (S): 885 @ $145.15 · Sale (S): 700 @ $146.04 · Sale (S): 500 @ $147.27 · +5 moreEDGAR
2026-05-284Mancini Anthony — See RemarksOption exercise (M): 3,121 @ $33.62 · Sale (S): 700 @ $153.30 · Sale (S): 2,000 @ $154.06 · Sale (S): 421 @ $154.82 · Option exercise (M): 3,121 (derivative) @ $0EDGAR
2026-04-294Mancini Anthony — See RemarksOption exercise (M): 3,120 @ $33.62 · Sale (S): 1,671 @ $131.66 · Sale (S): 1,049 @ $132.88 · Sale (S): 400 @ $134.34 · Option exercise (M): 3,120 (derivative) @ $0EDGAR
2026-04-174GOLDSMITH MARK A — See Remarks, DirectorOption exercise (M): 23,244 @ $4.09 · Option exercise (M): 96,756 @ $4.73 · Sale (S): 120,000 @ $150.09 · Option exercise (M): 23,244 (derivative) @ $0 · Option exercise (M): 96,756 (derivative) @ $0EDGAR
2026-03-264Mancini Anthony — See RemarksOption exercise (M): 37,450 @ $33.62 · Sale (S): 1,800 @ $93.22 · Sale (S): 3,128 @ $94.16 · Sale (S): 21,086 @ $95.49 · Sale (S): 11,036 @ $96.43 · Sale (S): 400 @ $97.21 · +1 moreEDGAR
2026-03-194Anders Jack — Chief Financial OfficerSale (S): 2,753 @ $99.48EDGAR
2026-03-194Cislini Jeff — General CounselSale (S): 1,795 @ $99.48 · Sale (S): 1,163 @ $97.44EDGAR
2026-03-194Wang Xiaolin — See RemarksSale (S): 2,010 @ $99.48EDGAR
2026-03-194Kelsey Stephen Michael — See RemarksSale (S): 4,302 @ $99.48EDGAR
2026-03-194Horn Margaret A — Chief Operating OfficerSale (S): 4,583 @ $99.48EDGAR
2026-03-194GOLDSMITH MARK A — See Remarks, DirectorSale (S): 12,871 @ $99.48EDGAR

Recent 8-K events — Revolution Medicines, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-138-K2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8.01 — Other Events
EDGAR
2026-09-018-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
EDGAR
2026-08-268-K8.01 — Other EventsEDGAR
2026-08-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-228-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
EDGAR
2026-05-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-178-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-168-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-138-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=RVMD returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs